Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients.
about
Prevalence of airflow obstruction in U.S. adults aged 40-79 years: NHANES data 1988-1994 and 2007-2010Quantification of heterogeneity in lung disease with image-based pulmonary function testing.The RESPECT study: RESearch on the PrEvalence and the diagnosis of COPD and its Tobacco-related etiology: a study protocolMulti-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equationsEstimating population prevalence of potential airflow obstruction using different spirometric criteria: a pooled cross-sectional analysis of persons aged 40-95 years in England and WalesImaging lung function in mice using SPECT/CT and per-voxel analysisGOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish populationRegional variations in the prevalence and misdiagnosis of air flow obstruction in China: baseline results from a prospective cohort of the China Kadoorie Biobank (CKB)The physiological basis and clinical significance of lung volume measurementsEffects of respiratory and non-respiratory factors on disability among older adults with airway obstruction: the Cardiovascular Health Study.Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.Audit on the appropriateness of integrated COPD management: the "ALT-BPCO" projectLung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects.Evaluation of the global lung function initiative 2012 reference values for spirometry in a Swedish population sampleCanadian prediction equations of spirometric lung function for Caucasian adults 20 to 90 years of age: results from the Canadian Obstructive Lung Disease (COLD) study and the Lung Health Canadian Environment (LHCE) study.Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.A retrospective study of two populations to test a simple rule for spirometry.Defining obstructive ventilatory defect in 2015.Do current OELs for silica protect from obstructive lung impairment? A critical review of epidemiological data.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.No change in prevalence of symptoms of COPD between 1996 and 2006 in Finnish adults - a report from the FinEsS Helsinki Study.Forced expiratory capnography and chronic obstructive pulmonary disease (COPD)A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.Pragmatic research and outcomes in asthma and COPDModels for estimating projections for the prevalence and disease burden of chronic obstructive pulmonary disease (COPD): systematic review protocol.Hyperpolarized 129Xenon Magnetic Resonance Imaging to Quantify Regional Ventilation Differences in Mild to Moderate Asthma: A Prospective Comparison Between Semiautomated Ventilation Defect Percentage Calculation and Pulmonary Function Tests.Reference values for spirometry and their use in test interpretation: A Position Statement from the Australian and New Zealand Society of Respiratory Science.Reversibility of airway obstruction vs bronchodilatation: do we speak the same language?Coexisting COPD in elderly asthma with fixed airflow limitation: Assessment by DLco %predicted and HRCT.The Global Lung Function Initiative (GLI) Network: bringing the world's respiratory reference values together.Quality of spirometry tests and pulmonary function changes among industrial company workers in Iran: a two-year before-and-after study following an intensive training intervention.The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction.Recovery of Pulmonary Function after Allogeneic Hematopoietic Cell Transplantation in Children is Associated with Improved Survival.Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement.New Reference Values for Cardiopulmonary Exercise Testing in Children.Lung Function Abnormalities in Smokers with Ischemic Heart Disease.The new all-age spirometry reference equations are the best available for Caucasians, regardless of where they live.Spirometric Criteria for Chronic Obstructive Pulmonary Disease in Clinical Trials of Pharmacotherapy.Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial.Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I.
P2860
Q23910517-445817BC-C446-43B7-BF31-F282D0F50007Q27331269-1D211748-D4C2-4983-AA5A-9DF760281BC1Q28387000-85561AC5-2170-4EF5-B4DC-82A9426EC69CQ28389258-E528C227-A861-4807-938B-ECB8159C46BCQ28391668-91ECA0BE-9728-4983-8A84-EBC919080766Q28482018-27B36CB9-DC0D-4D4F-AD0D-D7DF0A39EF9EQ28587875-51F773E0-6A05-4E7E-96AD-EB31284C32ECQ28654249-3942D5C8-82F4-4368-8035-D144C7BF07FAQ29248465-DF3BB6CD-F349-48BF-B4F3-A8AD46022904Q30569184-0907898C-094E-4906-860F-12F8097117C5Q30586386-85C481B4-2B71-468E-8577-3305DC920610Q34005418-C8C2B04E-D1CF-4D61-8A25-7329BEA46A3EQ34206825-D8F27390-B26C-4D07-8720-8BA418509052Q35562641-0A7ED009-3136-49C8-A681-D6517DF06C68Q35703771-0C41F0D2-0EE8-4252-AE9C-A5D9A9FEB5DDQ35851777-98499582-AC42-4B4B-8C3D-FFD8279F81F8Q36040501-963FFC3B-601D-443C-A85D-1C40D232DE66Q36143545-C24825CF-EF59-4DC6-AC5A-4DFE33D84DACQ36373826-DBBF1165-938A-4D47-8284-A0D5F084628BQ37177278-D188D25D-B877-418F-B803-A17295D5EE64Q37184888-718BB508-D72E-4631-BC70-F56244562398Q37246809-5D93E5E4-B9F5-4E2C-92B5-C6545D00FB36Q37276584-DA2C4C85-D611-4B97-AE95-7EF2CD260881Q37300877-7A8B858E-6EB0-4AE1-9419-902BAF5A26D1Q38111633-26CA50F1-B2E4-4871-8606-2921F4BB840DQ38962872-BE315768-7F98-4F94-B450-29594BB8D266Q39560303-6CF3FC3A-788B-4653-B743-9A3B592F3E33Q39632785-DFCA193D-75BD-4F32-AB1B-4171BD303D81Q40485516-BFEF2F24-1E6E-4698-9EC3-82EE6BFFD8D3Q41683637-15A642A6-A20E-4257-A700-BC15CAB65931Q45905213-F7157FF5-A875-442C-9ED6-2C6EFECE0445Q46774071-CB31F707-6F06-422B-AF8D-6E2D6B815760Q47099619-CD70E2D7-75C3-489B-A16F-72774ECE7197Q47387538-B47CA96C-93BF-4030-9819-6EAAE3866F74Q47561134-637D3345-4D42-4BC3-8704-C80B7E014A71Q48344798-C023274A-E9B5-4DDF-89EA-0A4F58CF8962Q51577163-07708BFE-5C78-47A1-8310-E6725A465B9BQ52690561-744604DA-50F8-44FC-BB83-89B2A52164E7Q55287198-B5BEB290-F7C9-4824-8285-838A1574F096Q55417861-6232C360-483C-4FC9-8C0C-5951EF7B01F7
P2860
Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interpreting lung function dat ...... ies more than 20% of patients.
@ast
Interpreting lung function dat ...... ies more than 20% of patients.
@en
type
label
Interpreting lung function dat ...... ies more than 20% of patients.
@ast
Interpreting lung function dat ...... ies more than 20% of patients.
@en
prefLabel
Interpreting lung function dat ...... ies more than 20% of patients.
@ast
Interpreting lung function dat ...... ies more than 20% of patients.
@en
P2093
P356
P1433
P1476
Interpreting lung function dat ...... ies more than 20% of patients.
@en
P2093
Gregg Ruppel
Martin R Miller
Maureen P Swanney
Paul L Enright
Philip H Quanjer
P356
10.1378/CHEST.10-0189
P407
P577
2010-06-03T00:00:00Z